latest update:
[RxAtlas]

drug summary · 2 NDC codes

RETACRIT 20000 [iU]/mL

epoetin alfa-epbx

HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status BLA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.

dataset id 61213NDC codes 2application BLA125545RxCUI —

Facts

Field definitions, types, and provenance rules are in the data dictionary.

generic nameepoetin alfa-epbx
active ingredientsEPOETIN
dosage formINJECTION, SOLUTION
routeINTRAVENOUS, SUBCUTANEOUS
strength20000 [iU]/mL
marketing statusBLA
DEA schedulenot reported
application numberBLA125545
ATC codenot reported
RxCUInot reported
manufacturerPfizer Laboratories Div Pfizer Inc
product typeHUMAN PRESCRIPTION DRUG
pharmacologic classErythropoiesis-stimulating Agent [EPC]; Erythropoietin [CS]; Increased Erythroid Cell Production [PE]

NDC codes

2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.

NDCPackage description
00069131110—
0069-1311—

Other epoetin alfa-epbx products

10 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.

Work with this record

  • Field definitions

    Types, scope, and provenance rules for every exported field.

  • REST API

    Query the same gate-backed records programmatically.

  • Evaluation sample

    Download a bounded slice before buying.

  • $29 API Pass

    Seven days of REST and MCP access to the full catalogue; credited toward the licence.